Behind "AIDS breakthrough" headlines, December 2004: important research, not so new.
The mid-December press reports about an AIDS drug breakthrough were exaggerated, but the research described is important. It concerns the development of a class of related experimental drugs that work like efavirenz or nevirapine, but appear to be more powerful and much less subject to resistance.